CTLA4 and colorectal cancer: Among the immune dynamics explored, we observed a consistent expansion of regulatory T cells (Tregs) following PD-1 blockade, a finding that aligns with its limited efficacy as monotherapy in pMMR colorectal cancers and its enhanced activity when combined with CTLA-4 inhibitors [43].